Continental Advisors’s Myriad Genetics MYGN Stock Holding History

Continental Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,892	Closed	-$452K	–	62
2022 Q2	$452K	Hold	24,892	–	–	0.27%	57
2022 Q1	$627K	Hold	24,892	–	–	0.31%	51
2021 Q4	$687K	Hold	24,892	–	–	0.29%	56
2021 Q3	$804K	Sell	24,892 -4,500	-15%	-$149K	0.34%	55
2021 Q2	$899K	Hold	29,392	–	–	0.41%	49
2021 Q1	$895K	Sell	29,392 -7,000	-19%	-$199K	0.41%	59
2020 Q4	$720K	Hold	36,392	–	–	0.33%	63
2020 Q3	$475K	Buy	36,392 +22,500	+162%	+$285K	0.25%	77
2020 Q2	$158K	Hold	13,892	–	–	0.08%	82
2020 Q1	$199K	Hold	13,892	–	–	0.15%	73
2019 Q4	$378K	Hold	13,892	–	–	0.18%	69
2019 Q3	$398K	Hold	13,892	–	–	0.24%	68
2019 Q2	$386K	Hold	13,892	–	–	0.22%	68
2019 Q1	$461K	Sell	13,892 -12,108	-47%	-$369K	0.21%	80
2018 Q4	$756K	Hold	26,000	–	–	0.23%	86
2018 Q3	$1.2M	Hold	26,000	–	–	0.26%	81
2018 Q2	$972K	Hold	26,000	–	–	0.24%	82
2018 Q1	$768K	Hold	26,000	–	–	0.19%	86
2017 Q4	$893K	Sell	26,000 -9,200	-26%	-$310K	0.19%	91
2017 Q3	$1.27M	Sell	35,200 -24,900	-41%	-$710K	0.29%	78
2017 Q2	$1.55M	Hold	60,100	–	–	0.35%	80
2017 Q1	$1.15M	Hold	60,100	–	–	0.26%	93
2016 Q4	$1M	Buy	60,100 +28,000	+87%	+$507K	0.27%	93
2016 Q3	$661K	Buy	+32,100	New	+$814K	0.18%	111

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Continental Advisors's MYGN Position: Q3 2022 in Review

Continental Advisors sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 24,892 shares — an estimated $452K sold.

Continental Advisors first reported a position in MYGN in Q3 2016 and held it in 24 quarters. The position peaked at $1.55M in Q2 2017. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

Continental Advisors reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
Continental Advisors sold 24,892 Myriad Genetics shares in Q3 2022, an estimated $452K.
Continental Advisors first reported a position in Myriad Genetics in Q3 2016 and held it in 24 quarters.
Continental Advisors's Myriad Genetics position peaked at $1.55M in Q2 2017.
191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Continental Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.